---
title: "国药科技股份有限公司 (08156.HK)"
type: "quote"
locale: "en"
url: "https://longbridge.com/en/quote/08156.HK.md"
symbol: "08156.HK"
name: "国药科技股份有限公司"
industry: "医疗产品分销商"
---

# 国药科技股份有限公司 (08156.HK)

| Item | Detail |
|------|--------|
| Industry | 医疗产品分销商 |
| Location | 港股市场 |
| Website | [www.sinopharmtech.com.hk](https://www.sinopharmtech.com.hk) |

## Company Profile

本集团的主要业务为 (i) 提供彩票相关服务;(ii) 提供互联网 + 解决方案服务;及 (iii) 其他服务 (包括餐饮服务和咨询服务)。

## Financial Score

> *Longbridge Financial Score™ — Proprietary multi-factor rating model by [Longbridge](https://longbridge.com). This score is independently calculated by Longbridge and is not affiliated with any third-party rating agency.*
> Updated: 2026-02-15T04:30:11.000Z

**Overall: C (0.47)**

**Industry**: Health Care Distributors

| Metric | Value |
|--------|-------|
| Industry Ranking | 13 / 21 |
| Industry Median | C |
| Industry Average | C |

- **Style**: Blend - Stocks in which the company has both growth and mature businesses.
- **Scale**: Small - The company's operation has a high degree of growth and volatility, making it easy to achieve high investment returns.

### Score Analysis

**Style Score**: 

#### Growth Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | 48.39% |  |
| Net Profit YoY | 95.60% |  |

#### Value Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| P/B Ratio | -4.73 |  |
| Dividend Ratio | 0.00% |  |


**Size Score**: 

#### Market Cap Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Market Cap | 174.23M |  |

#### Revenue Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue | 61.24M |  |


**Multi Score**: C

#### Profit Score: D

| Indicator | Value | Rating |
|-----------|-------|--------|
| ROE | 0.49% | D |
| Profit Margin | -1.42% | D |
| Gross Margin | 23.23% | D |

#### Growth Score: A

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | 48.39% | A |
| Net Profit YoY | 95.60% | A |
| Total Assets YoY | 16.29% | A |
| Net Assets YoY | 82.15% | A |

#### Cash Score: C

| Indicator | Value | Rating |
|-----------|-------|--------|
| Cash Flow Margin | -7064.94% | E |
| OCF YoY | 48.39% | A |

#### Operating Score: A

| Indicator | Value | Rating |
|-----------|-------|--------|
| Turnover | 1.27 | A |

#### Debt Score: E

| Indicator | Value | Rating |
|-----------|-------|--------|
| Gearing Ratio | 170.93% | E |


```chart-data:radar
{
  "title": "Longbridge Financial Score - 国药科技股份有限公司",
  "chart_type": "radar",
  "dimensions": [
    {
      "name": "Profit",
      "grade": "D",
      "indicators": [
        {
          "name": "ROE",
          "value": "0.49%",
          "rating": "D"
        },
        {
          "name": "Profit Margin",
          "value": "-1.42%",
          "rating": "D"
        },
        {
          "name": "Gross Margin",
          "value": "23.23%",
          "rating": "D"
        }
      ]
    },
    {
      "name": "Growth",
      "grade": "A",
      "indicators": [
        {
          "name": "Revenue YoY",
          "value": "48.39%",
          "rating": "A"
        },
        {
          "name": "Net Profit YoY",
          "value": "95.60%",
          "rating": "A"
        },
        {
          "name": "Total Assets YoY",
          "value": "16.29%",
          "rating": "A"
        },
        {
          "name": "Net Assets YoY",
          "value": "82.15%",
          "rating": "A"
        }
      ]
    },
    {
      "name": "Cash",
      "grade": "C",
      "indicators": [
        {
          "name": "Cash Flow Margin",
          "value": "-7064.94%",
          "rating": "E"
        },
        {
          "name": "OCF YoY",
          "value": "48.39%",
          "rating": "A"
        }
      ]
    },
    {
      "name": "Operating",
      "grade": "A",
      "indicators": [
        {
          "name": "Turnover",
          "value": "1.27",
          "rating": "A"
        }
      ]
    },
    {
      "name": "Security",
      "grade": "E",
      "indicators": [
        {
          "name": "Gearing Ratio",
          "value": "170.93%",
          "rating": "E"
        }
      ]
    }
  ]
}
```

### Peer Comparison

| Rank | Name | Profit | Growth | Operation | Security | Cash | Rating |
|------|------|--------|--------|-----------|----------|------|--------|
| 01 | 药师帮 (HK.9885) | C | B | A | D | B | B |
| 02 | GUANZE MEDICAL (HK.2427) | B | A | C | A | B | B |
| 03 | 君百延集团 (HK.8372) | B | B | B | A | B | B |
| 04 | 上海医药 (HK.2607) | C | C | A | D | B | C |
| 05 | 白云山 (HK.874) | C | C | A | C | B | C |

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | -201.00 | 22/23 | - | - | - |
| PB | -4.73 | 21/23 | - | - | - |
| PS (TTM) | 2.85 | 20/23 | 3.52 | 3.05 | 1.84 |
| Dividend Yield | 0.00% | - | - | - | - |

## References

- [Company Overview](https://longbridge.com/en/quote/08156.HK/overview.md) - Shareholders, executives, business segments
- [Financials](https://longbridge.com/en/quote/08156.HK/norm.md) - Income statement, balance sheet, cash flow, distribution plan
- [Topics & Discussions](https://longbridge.com/en/quote/08156.HK/topics.md) - Community topics and discussions

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.